Rony Chanoch-Myers, PhD

Rony joined the lab as a research fellow in September 2024 after completing her PhD in Itay Tirosh’s lab at the Weizmann Institute, where she focused on intra-tumor heterogeneity in glioblastoma. A computational biologist with a strong interest in cancer research, Rony is interested in studying the epigenetic mechanisms that drive tumorigenesis.

Daniel Solvie, PhD

Daniel joined the Bernstein Lab as a research fellow in November 2023. He completed his PhD in the lab of Martin Eilers at JMU Wuerzburg in Germany, studying the molecular mechanisms of the oncoprotein MYC as a stress resilience factor.

Shelby Roseman, PhD

Shelby joined the lab as a research fellow in October 2023 after completing her PhD at Harvard University. During her PhD, she used chemical genomics to study 3D chromatin structure. She is interested in understanding and targeting the epigenetic mechanisms that contribute to cancer.

Eran Hodis, MD, PhD

Eran is a Medical Oncology Fellow at Dana-Farber/Mass-General Brigham where he treats patients with melanoma. He completed his M.D. at Harvard Medical School and MIT, and his Ph.D. at Harvard University in biophysics where his work focused on elucidating and studying the somatic mutations that cause cancer, with a focus on melanoma. He joined the … Continued

James Morrow, MD, PhD

James is a Pediatric Oncology Fellow at Dana-Farber/Boston Children’s Hospital where he currently treats pediatric patients with cancer diagnoses. He completed his MD/PhD at Case Western Reserve University. His graduate work identified enhancer dysregulation as a driver of osteosarcoma metastasis. He joined the Bernstein lab in September 2022 as a research fellow. His work will apply single cell … Continued